Five‐year experience in the treatment of focal movement disorders with low‐dose dysportTM botulinum toxin

Muscle & Nerve

Volumn 18, Issue 7, 1995, Pages 720-729

  Van Den Bergh, P ^a   Francart, J ^a   Mourin, S ^a   Kollmann, P ^a   Laterre, E C ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

botulinum toxin; electromyographic guidance; focal dystonia; hemifacial spasm; movement disorders

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; BLEPHAROSPASM; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SCREENING; DYSPHAGIA; DYSTONIA; ELECTROMYOGRAM; FEMALE; HEMIFACIAL SPASM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEIGE DISEASE; MOTOR DYSFUNCTION; MUSCLE CRAMP; PRIORITY JOURNAL; RELAPSE; WRITING;

ADULT; AGED; BLEPHAROSPASM; BOTULINUM TOXINS; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSTONIA; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; MEIGE SYNDROME; MIDDLE AGE; MOVEMENT DISORDERS; MUSCLE CRAMP; SPASM; TIME FACTORS; VIDEOTAPE RECORDING;

EID: 0029041999     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.880180708     Document Type: Article

References (49)

1. Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum)
2. Management of hemifacial spasm with botulinum A toxin
3. Botulinum toxin treatment in spasmodic torticollis
4. Botulinum toxin for treatment of oromandibular dystonia
5. Effectiveness of botulinum toxin in the treatment of spasmodic torticollis
6. Hemifacial spasm: evaluation and management, with emphasis on botulinum toxin therapy
7. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
8. Botulinum toxin: dangerous terminology errors
9. Oromandibular dystonia: treatment of 96 patients with botulinum toxin type A
10. Hand cramps: clinical features and electromyographic patterns in a focal dystonia
11. Treatment of focal dystonias of the hand with botulinum toxin injections
12. Local treatment of hand cramps with botulinum toxin (Botox)
13. Botulinum toxin injection for spasmodic torticollis: increased benefit with electromyographic assistance
14. Low dose botulinum toxin in spasmodic torticollis
15. Electromyographic guidance of botulinum toxin treatment in cervical dystonia
16. An electron microscopic study of the changes induced by botulinum toxin in the motor end‐plates of slow and fast skeletal muscle fibers of the mouse
17. Long‐term results and complications of botulinum A toxin in the treatment of blepharospasm
18. Management of blepharospasm and hemifacial spasm
19. Hemifacial spasm
20. Effectiveness of botulinum toxin therapy for essential blepharospasm
21. Botulinum toxin: preferred treatment for hemifacial spasm
22. Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis
23. Double‐blind, placebo‐controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis
24. Treatment of oromandibular dystonia with botulinum toxin
25. Botulinum A toxin for cranial–cervical dystonia: a double‐blind, placebo‐controlled study
26. Botulinum toxin treatment of cranial–cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm
27. Therapeutic uses of botulinum toxin
28. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia
29. Long‐term botulinum toxin treatment of focal hand dystonia
30. Treatment of cervical dystonia, hand spasms, and laryngeal dystonia with botulinum toxin
31. Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double‐blind study on twenty‐three patients
32. Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias
33. A double blind trial of botulinum toxin “A” in torticollis, with one year follow up
34. Treatment of spasmodic torticollis with local injections of botulinum toxin
35. Experience with botulinum toxin in cervical dystonia
36. Dose standardisation of botulinum toxin
37. Long‐term treatment of involuntary facial spasms using botulinum toxin
38. Hemifacial spasm treated with botulinum A toxin injection
39. Traitement des blépharospasmes et des hémispasmes faciaux par injection de toxine botulique
40. Preparation and characterization of botulinum toxin type A for human treatment
41. Botulinum A toxin injection as a treatment for blepharospasm
42. Writer's cramp—a focal dystonia
43. Molecular pharmacology of botulinum toxin and tetanus toxin
44. Botulinum toxin in spasmodic torticollis
45. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicenter study
46. Assessment: The clinical usefulness of botulinum toxin‐A in treating neurologic disorders
47. A pilot study on the use of botulinum toxin in spasmodic torticollis
48. Dystonia—a clinical, neuropathological and therapeutic review
49. Botulinum toxin therapy for limb dystonias